174 related articles for article (PubMed ID: 25131339)
1. Graphene nanoribbons as a drug delivery agent for lucanthone mediated therapy of glioblastoma multiforme.
Chowdhury SM; Surhland C; Sanchez Z; Chaudhary P; Suresh Kumar MA; Lee S; Peña LA; Waring M; Sitharaman B; Naidu M
Nanomedicine; 2015 Jan; 11(1):109-18. PubMed ID: 25131339
[TBL] [Abstract][Full Text] [Related]
2. Cell specific cytotoxicity and uptake of graphene nanoribbons.
Mullick Chowdhury S; Lalwani G; Zhang K; Yang JY; Neville K; Sitharaman B
Biomaterials; 2013 Jan; 34(1):283-93. PubMed ID: 23072942
[TBL] [Abstract][Full Text] [Related]
3. Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.
Naidu MD; Agarwal R; Pena LA; Cunha L; Mezei M; Shen M; Wilson DM; Liu Y; Sanchez Z; Chaudhary P; Wilson SH; Waring MJ
PLoS One; 2011; 6(9):e23679. PubMed ID: 21935361
[TBL] [Abstract][Full Text] [Related]
4. Graphene nanoribbons elicit cell specific uptake and delivery via activation of epidermal growth factor receptor enhanced by human papillomavirus E5 protein.
Mullick Chowdhury S; Manepalli P; Sitharaman B
Acta Biomater; 2014 Oct; 10(10):4494-504. PubMed ID: 24980059
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
6. Decreased APE-1 by Nitroxoline Enhances Therapeutic Effect in a Temozolomide-resistant Glioblastoma: Correlation with Diffusion Weighted Imaging.
Cho HR; Kumari N; Thakur N; Vu HT; Kim H; Choi SH
Sci Rep; 2019 Nov; 9(1):16613. PubMed ID: 31719653
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
8. Abasic sites in DNA of HeLa cells induced by lucanthone.
Mendez F; Goldman JD; Bases RE
Cancer Invest; 2002; 20(7-8):983-91. PubMed ID: 12449731
[TBL] [Abstract][Full Text] [Related]
9. Sonosensitizer-Functionalized Graphene Nanoribbons for Adhesion Blocking and Sonodynamic Ablation of Ovarian Cancer Spheroids.
Lee HR; Kim DW; Jones VO; Choi Y; Ferry VE; Geller MA; Azarin SM
Adv Healthc Mater; 2021 Jul; 10(13):e2001368. PubMed ID: 34050609
[TBL] [Abstract][Full Text] [Related]
10. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
11. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
[TBL] [Abstract][Full Text] [Related]
12. Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment.
Gao H; Yang Z; Cao S; Xiong Y; Zhang S; Pang Z; Jiang X
Biomaterials; 2014 Feb; 35(7):2374-82. PubMed ID: 24342723
[TBL] [Abstract][Full Text] [Related]
13. Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1.
Naidu MD; Mason JM; Pica RV; Fung H; Peña LA
J Radiat Res; 2010; 51(4):393-404. PubMed ID: 20679741
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
15. Adsorption of Cisplatin on Oxidized Graphene Nanoribbons for Improving the Uptake in Non-small Cell Lung Carcinoma Cell Line A549.
Augustine S; Prabhakar B; Shende P
Curr Drug Deliv; 2022; 19(6):697-705. PubMed ID: 34238188
[TBL] [Abstract][Full Text] [Related]
16. Graphene oxide nanoribbons as nanomaterial for bone regeneration: Effects on cytotoxicity, gene expression and bactericidal effect.
Ricci R; Leite NCS; da-Silva NS; Pacheco-Soares C; Canevari RA; Marciano FR; Webster TJ; Lobo AO
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():341-348. PubMed ID: 28575993
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors.
Srinivasan A; Wang L; Cline CJ; Xie Z; Sobol RW; Xie XQ; Gold B
Biochemistry; 2012 Aug; 51(31):6246-59. PubMed ID: 22788932
[TBL] [Abstract][Full Text] [Related]
18. In vitro osteogenesis process induced by hybrid nanohydroxyapatite/graphene nanoribbons composites.
de Vasconcellos LMR; do Prado RF; Sartori EM; Mendonça DBS; Mendonça G; Marciano FR; Lobo AO
J Mater Sci Mater Med; 2019 Jun; 30(7):81. PubMed ID: 31254104
[TBL] [Abstract][Full Text] [Related]
19. Graphene Oxide Nanoribbons Induce Autophagic Vacuoles in Neuroblastoma Cell Lines.
Mari E; Mardente S; Morgante E; Tafani M; Lococo E; Fico F; Valentini F; Zicari A
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916824
[TBL] [Abstract][Full Text] [Related]
20. Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomide.
Cui Y; Naz A; Thompson DH; Irudayaraj J
Mol Pharm; 2015 Apr; 12(4):1279-88. PubMed ID: 25751281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
